Re‐exploring Tissue Regeneration by Novel Spatial Transcriptomics Technologies
Xiaoyü Wei,Hanbo Li,Jiaxin Du,Xiaoqi Zeng,Xun Xu,Liang Chen,Ying Gu
DOI: https://doi.org/10.1002/ctm2.1127
IF: 8.554
2022-01-01
Clinical and Translational Medicine
Abstract:One of the ultimate goals of regenerative medicine is to replace damaged tissues using natural growth and repair mechanisms, which barely remain in adult human body. In contrast, certain lower vertebrates, such as salamanders and zebrafish, exhibit an incredible ability to regenerate various damaged body parts both structurally and functionally. These animals with such natural gifts have therefore drawn the long-term attention of biologists, who are dedicated to uncovering the molecular mechanisms that direct programmed regeneration and how regenerative medicine practice would learn from fundamental scientific discoveries. While early efforts focused on one or a few molecules/pathways/cell types have extensively substantiated our understanding in this field,1 the gap between the enormous complexity of regenerative responses and the low-throughput readout of the canonical methods has hindered scientists from elaborating the mechanism systematically. To tackle this bottleneck issue, single-cell RNA sequencing technologies (scRNA-seq) were introduced into the field recently. They can capture molecular characteristics and dynamics of every known cell type and help identify new or transient cell states. Applying scRNA-seq to axolotl limb regeneration, researchers discovered a critical cell state transition from connective tissue to blastema cells required for lost tissue reconstruction in a later stage,2 possibly via the epithelial-mesenchymal transition mechanism.3 ATAC-seq data further provided rich chromatin regulatory information and deepened our understanding of the molecular basis of limb regeneration dynamics.4 Single-cell multi-omics have remarkably empowered us with global pictures and networking perspectives, yet they have inherent limitations, too. Spatial information of cells is lost when constructing scRNA-seq libraries, including cell distribution and identities of the neighboring microenvironment, thus hampering the in-depth investigation of the biological process of a tissue or organ in situ. To this end, new spatial transcriptomics technologies developed recently stand out to be a solution, such as microdissection-based cell capture and sequencing laser capture microdissection (LCM, Geo-seq), high throughput in situ hybridization (smFISH, MERFISH), in situ sequencing (STARmap), and in situ capturing technologies (Stereo-seq, Slide-seq),5 some of which (Stereo-seq, Seq-Scope, and sci-Space) reach a single-cell or subcellular resolution. Combining the accurate information of the transcript coordinate and hundreds of genes detected in a single spot on the chip, scientists can not only obtain the physical location and transcription profile of each cell on the section, but also redefine the cell types and even tissue anatomy of a given organ at the molecular level. Investigations that are difficult for single cell omics method, such as cell state trajectory along the certain anatomical route of tissue for differentiation, and cell-cell communication and microenvironment within the boundary of disease versus healthy areas, would be achieved by spatial transcriptomics to target key questions in development and disease mechanism. For example, Chen et al. constructed exquisite spatiotemporal maps of developmental mouse embryos at single-cell resolution.6 Together with the organ atlas of several other species published recently, these spatial transcriptomics profiles provide valuable mechanistic insights into the cell fate specification in developing tissues.7 For clinical research, by focusing on the invasive fronts of intrahepatic cholangiocarcinoma, Wu et al. observed the distinct immune microenvironment that may promote tumour invasion.8 Ou et al. found unique immune cell types enriched in tumour areas with different metabolic activity.9 By analyzing neighboring cell composition from spatial transcriptomics data, Cong et al. identified a specific macrophage subgroup for SARS-CoV-2 clearance and inflammation resolution10 (Figure 1). In the regeneration field, a multi-institute research team led by BGI-research recently applied Stereo-seq to reveal how a brain injury heals by itself in axolotls, which was published as the cover story in Science.11 By constructing the first single-cell spatial profile of axolotl telencephalon throughout development, Wei et al. redefined ependymoglial cells (EGCs), the neural stem cells in the axolotl brain, into three transcriptomically distinct subgroups distributed separately in the ventricular zone. During telencephalon regeneration, Stereo-seq data showed that a new EGC subpopulation from local resident EGCs near the injury site, namely reactive EGCs (reaEGCs), was activated, which proliferated and moved to cover the injury site, then replenished lost neurons through a state transition to intermediate progenitors, immature and eventually mature neurons. Notably, such brain regeneration led by reaEGCs partially recapitulated the developmental program at the molecular level and in the spatial distribution of cells of the same state11 (Figure 2A). While scientists have speculated that brain regeneration resembles brain development to some extent, efforts by Wei et al. have demonstrated this long-standing hypothesis by providing exquisite spatial transcriptomic evidence, which implies that improved activation of progenitor cells might be a promising avenue for brain regeneration. When increasing spatial transcriptomics data of the tissue regeneration in different species become available, cross-species comparion would be performed to provide more insights into the mechanism of limited regeneration ability of higher vertebrates, and explore possibilities, such as stimulated stem cell activation, to imporve tissue regeneration of mammals, including human, in the future. Spatial transcriptomics strategies make a glimpse of all the behaviors of all cells in situ at the same time into reality. Here, we anticipate several research directions in spatial-omics development and potential application in the future. First, technological improvement in sample applicability, higher throughput and transcript capturing efficiency, greater sequencing depth, and more data analyzing tools to expand the application; Second, the development of spatial multi-omics technologies beyond transcriptomics, including genomics, proteomics, metabolomics, and metagenomics to realize more research perspectives. Third, the accomplishment of spatial transcriptomics from 2D to 3D will provide a complete picture of the research subject at the tissue, cell, and molecular levels. With unprecedented technological advances, spatial-omics technologies, like Stereo-seq, will further shift the paradigm of many basic research fields, such as the development of plants and animals, aging, and tissue regeneration. They may also greatly promote our understanding of disease mechanisms from the tissue or even system point of view, such as cancer, infection, and metabolic and neurological diseases. We also anticipate that as spatial-omics technologies become more available beyond basic research, they may have broader applications in clinical practice, as a comprehensive and advanced dissection tool for disease diagnosis and post-treatment examination (Figure 2B). The authors thank Ji-Feng Fei from Guangdong Provincial People's Hospital and An Zeng from Center for Excellence in Molecular Cell Science for critical reading of the manuscript and providing invaluable comments. This work was supported by National Key R&D Program of China (grant numbers: 2021YFA1100500 and 2022YFC3400400). The authors declare no conflict of interest.